Task: Answer the multiple-choice question.
Question: Which drug exhibits a -2.274% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, or c without using any additional words.
Options:
a) Cc1ccc(NC(=O)Nc2cnccn2)cc1
b) CCc1ccc2c(c1)c1nnc(NN)nc1n2C
c) CSc1sc(C(=O)N(C)C)c2c1S(=O)(=O)N(C)c1ccccc1-2
Answer: c. CSc1sc(C(=O)N(C)C)c2c1S(=O)(=O)N(C)c1ccccc1-2
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CSc1sc(C(=O)N(C)C)c2c1S(=O)(=O)N(C)c1ccccc1-2
CSc1sc(C(=O)N(C)C)c2c1S(=O)(=O)N(C)c1ccccc1-2
N,N,5-trimethyl-3-methylsulfanyl-4,4-dioxothieno[3,4-c][2,1]benzothiazine-1-carboxamide